1. Home
  2. MTRX vs RCKT Comparison

MTRX vs RCKT Comparison

Compare MTRX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matrix Service Company

MTRX

Matrix Service Company

HOLD

Current Price

$11.91

Market Cap

328.5M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.25

Market Cap

340.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTRX
RCKT
Founded
1984
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.5M
340.9M
IPO Year
1990
N/A

Fundamental Metrics

Financial Performance
Metric
MTRX
RCKT
Price
$11.91
$3.25
Analyst Decision
Strong Buy
Buy
Analyst Count
1
14
Target Price
$17.00
$29.12
AVG Volume (30 Days)
225.6K
2.0M
Earning Date
02-04-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$815,591,000.00
N/A
Revenue This Year
$20.43
N/A
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.16
N/A
52 Week Low
$9.33
$2.19
52 Week High
$16.11
$13.35

Technical Indicators

Market Signals
Indicator
MTRX
RCKT
Relative Strength Index (RSI) 46.33 47.12
Support Level $11.68 $3.30
Resistance Level $12.59 $3.57
Average True Range (ATR) 0.42 0.19
MACD 0.09 0.00
Stochastic Oscillator 49.44 28.95

Price Performance

Historical Comparison
MTRX
RCKT

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: